Primary Care Clinical Digest | January 26 2024

PRIMARY CARE CLINICAL DIGEST JANUARY 26 2024 What’s in this issue?

1.

2.

3.

Ruruku – Latest News and Updates from Te Whatu Ora and Te Aka Whai Ora View online Goodfellow Unit Webinars and Podcast

The Health Media Everybody Patient Sheets Updated for 2024 View online

4.

5.

6.

•

•

• • • •

•

National Clinical Networks Leader Announced

•

•

Ruruku – Latest News and Updates from Te Whatu Ora and Te Aka Whai Ora Goodfellow Unit Webinars and Podcast The Health Media - Everybody Patient Sheets Updated for 2024 National Clinical Networks Leader Announced Prazosin Tablets Supply Update Top Weekend Viewing (will start up again in February) Please see the link to the latest Ruruku from Te Whatu Ora and Te Aka Whai Ora

Upcoming webinars and podcast from the Goodfellow unit include: o Respiratory infections in children January 30 2024 Register here o Healthier clinicians February 13 2024 Register here o Hepatitis elimination and management March 12 2024 Register here o Podcast – Frail patients Podcast and resources here If you are a New Zealand Doctor subscriber, the new and updated 2024 Everybody Patient Sheets are now available to download.

Make sure you have only the most recent version saved to your computer by deleting your current set before downloading the new ones.

Click here to download the current, updated 2024 set. You will be taken to the New Zealand Doctor website, where you can login to download the new sheets.

Downloading files from unsolicited emails can be concerning. Please be assured, that this is a legitimate update service from The Health Media, publishers of New Zealand Doctor|Rata Aotearoa and Pharmacy Today|Kaitiaki Rongoā o te Wā newspapers.

If you have any feedback on the sheets, or there are topics you would like to see included, please don’t hesitate to get in touch with us by emailing enquiries@thehealthmedia.co.nz.

The National Clinical Networks programme, tasked with reducing variation in health outcomes for New Zealanders, has taken a major step with the announcement of leadership for four new Networks.

The joint Te Whatu Ora and Te Aka Whai Ora appointments of experts to lead the Critical Care, Eye Health, Radiology and Infection Services National Clinical Networks builds on the Stroke, Cardiac, Trauma and Renal Networks which were established late last year.

•

Prazosin Tablets Supply Update

• •

•

•

•

• • Top Weekend Viewing

•

The new National Clinical Network appointees are: o Critical Care: Nayda Heays, Hawke’s Bay and Alex Psirides, Wellington o Eye Health: Alistair Papali’i-Curtin, Wellington and Sarah Welch, Auckland o Infection Services*: Carolyn Clissold, Wellington o Radiology*: Sharyn MacDonald, Christchurch Read their bios here.

Please note: *Expressions of interest remain open for a second co-lead for both Radiology and Infection Services and will be announced when appointments are confirmed.

Read more about the National Clinical Networks.

The recent global supply issue affecting all strengths of prazosin tablets (1 mg, 2 mg, and 5 mg Arrotex-Prazosin S29) was due to a fire at the manufacturing plant that makes the active pharmaceutical ingredient for prazosin.

From January 23 2024, Pharmac have temporarily listed an alternate brand of prazosin tablets – Minipress® S29 (1 mg, 2 mg, and 5 mg), supplied by Pfizer. This information has been updated here. Pfizer can supply two to three months of this brand (at current usage rates), while Pharmac continues to work through options.

Please note that Te Whatu Ora Sector Operations will be unable to process claims for January dispensings of the above new listing until the first claim submitted in February.

Please either hold claims for these dispensings and submit with the first claim batch for February, or resubmit these claims from February 1.

The Minipress brand of prazosin tablet has not been approved by Medsafe and will need to be supplied in line with Section 29 of the Medicines Act 1981. The currently available Arrotex-Prazosin brand is also supplied under section 29. While the Minipress brand is not approved for use in New Zealand, it is approved and supplied in Australia.

Pharmac continues to explore all options to source a longterm alternate supply of prazosin.

Please visit the prazosin medicines notice for more information.

We will recommence with our top weekend viewing in February. Look out for some great recommendations!